Fubao Wang
General Counsel bei PRIME MEDICINE, INC.
Profil
Fubao Wang is a Senior VP & Head-Regulatory Affairs at Prime Medicine, Inc. He previously worked as a Director-Regulatory Affairs at Merck & Co., Inc., Vice President & Head-Regulatory at Sarepta Therapeutics, Inc., Associate Vice President at Sanofi, and Senior Vice President & Head-Regulatory Affairs at Asklepios BioPharmaceutical,.
Inc. Wang holds a doctorate from Ruprecht-Karls-Universität Heidelberg and undergraduate and graduate degrees from Nankai University.
Aktive Positionen von Fubao Wang
| Unternehmen | Position | Beginn |
|---|---|---|
| PRIME MEDICINE, INC. | General Counsel | - |
Ehemalige bekannte Positionen von Fubao Wang
| Unternehmen | Position | Ende |
|---|---|---|
| SANOFI | Corporate Officer/Principal | - |
| SAREPTA THERAPEUTICS, INC. | General Counsel | - |
| MERCK & CO., INC. | General Counsel | - |
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | General Counsel | - |
Ausbildung von Fubao Wang
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
| Nankai University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| PRIME MEDICINE, INC. | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| SANOFI | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Asklepios BioPharmaceutical, Inc.
Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Health Technology |
